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Abstract
Controlled oxygenated rewarming (COR) up to 20°C during ex vivo machine perfusion 
limits reperfusion- induced tissue injury upon graft implantation. Rewarming up to nor-
mothermia might add further benefits and provide better prediction of post- 
transplantation organ function. The effect of 90 minutes of oxygenated machine 
perfusion with Aqix RS- I after cold storage combined with gentle rewarming up to 
20°C (COR20) or 35°C (COR35) was studied in rat livers and compared with cold stor-
age alone (CS, n = 6, resp). Postpreservation recovery was evaluated upon warm rep-
erfusion using an established in vitro system. COR generally resulted in significantly 
improved energetic recovery, increased bile flow, less activities alanine aminotrans-
ferase (ALT) release, and improved histopathology upon reperfusion as compared to 
only cold- stored livers, without significant differences between COR20 and COR35. 
Parameters obtained during COR, especially during COR35, also allowed for predic-
tion of hepatic recovery upon reperfusion. For instance, ulterior bile production upon 
reperfusion was found closely correlated to bile flow observed already during COR35 
(R2 = 0.91). COR significantly improved liver quality after static cold storage. Elevation 
of machine perfusion temperature up to 35°C may prove promising to refine ex vivo 
evaluation of the graft prior to transplantation.
K E Y W O R D S
controlled oxygenated rewarming, liver preservation, machine perfusion, organ reconditioning
1  | INTRODUCTION
One of the major restrictions in transplantation medicine is the  limited 
number of available donor organs. Due to this imbalance between 
donor organs and waiting recipients, the criteria of organ selection 
were extended and grafts of lesser quality became increasingly ac-
cepted to be transplanted.1 The use of these “less- than- optimal” grafts 
provides new challenges in transplantation research with regard to 
organ preservation and conditioning.2 New ex vivo strategies for main-
tenance and improvement of organ function could prevent storage 
and reperfusion- induced tissue injury and could therefore result in 
 decreased post- transplantation graft dys- or nonfunction.3
Organ preservation traditionally includes flush- out with appro-
priate preservation solutions followed by cold storage under hypoxic 
conditions.4 Problems associated with this technique are hypoxia- 
induced apoptotic events as well as activation of pro- inflammatory 
mediators, which influence post- transplantation organ function and 
integrity.5 Previous research evidenced that main destructive effects 
rather establish during exposure of organs to blood circulation after 
implantation than during the ischemic cold storage period itself.6
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The quality loss of organs during ex vivo organ preservation re-
sulted in the invention of new preservation techniques with the aim 
to recondition grafts prior to transplantation. It was found that brief 
hypothermic oxygenated machine perfusion (HMP) prior to organ 
transplantation significantly improves organ integrity and leads to 
decreased numbers of cases of post- transplantation graft dys- and 
nonfunction.7,8 This optimization is related to a reduced release of 
reactive oxygen species (ROS) during HMP and less oxidative stress 
upon  restoration of blood flow at normothermic conditions.9
Further experiments have indicated that rewarming of the organ 
during oxygenated machine perfusion could further contribute to im-
proved organ integrity and in vivo functionality through an adapted 
increase in metabolic activity of mitochondria and tissue cells.10 
Controlled oxygenated rewarming (COR) to 20°C was already shown 
to have protective capacities and improves organ recovery upon 
reperfusion.11
So far, extracorporeal temperature rise during COR had been lim-
ited to 20°C, as perfusion solutions had been used that were specifi-
cally designed for organ protection at hypothermia and might become 
inappropriate perfusates at increasing temperatures. However, COR 
up to normothermia might be advantageous over COR 20°C and could 
potentially provide the detection of functional markers for a more 
 reliable prediction of post- transplantation organ quality.
Aqix RS- I is a novel extracellular- type solution, which has the ca-
pability to maintain pH stability over a wide temperature range and 
has proven an appropriate preservation solution up to normothermic 
conditions.12
This study thus was designed to compare the suitability of liver 
reconditioning by COR up to varying temperatures (20°C and 35°C) 
by machine perfusion. The potential and optimal regeneration condi-
tions for damaged livers by short- term preimplantation ex vivo liver 
 perfusion were evaluated.
2  | MATERIALS AND METHODS
The experiments were performed according to the federal law regu-
lating the protection of animals and follow the principles of labora-
tory animal care (NIH publication vol 25, No 28, revised 1996). Male 
Wistar rats with a weight between 250 and 300 g were anesthetized 
using isoflurane (induction with 4%). Ketamine (75 mg/kg bw) was 
intraperitoneally injected as additional analgesia. The abdomen was 
exposed by midline incision and exsanguination of the animal induced 
by incision of the infrarenal aorta. Thirty minutes after cardiac ar-
rest, the portal vein was cannulated and the liver rinsed via the portal 
vein with 60 mL of histidine- tryptophan- ketoglutarate (HTK) solution 
(Köhler Chemie, Germany). After hepatectomy, the liver was finally 
cold stored overnight in HTK for 18 hours at 4°C.
2.1 | Controlled oxygenated rewarming (COR)
After 18 hours of static preservation at 4°C, some grafts were put on a 
home- made machine perfusion circuit, and 200 mL of Aqix RS- I solution 
was recirculated through the portal vein in a constant pressure mode 
imitating the way described earlier in larger organs.11 The solution was 
oxygenated through a thin- wall silicone tubing curled in a box, which 
was ventilated with a 95% O2- 5% CO2 gas mixture to allow for sufficient 
tissue aerobiosis during the rewarming process.13 Thus, oxygen partial 
pressures, measured with a temperature compensated fiber optic oxygen 
meter (Fibox3 LCD, PreSens precision sensing, Regensburg, Germany) at 
the venous effluent, did always exceed 200 mm Hg. After 30 minutes of 
hypothermic perfusion, controlled rewarming of the perfusate was per-
formed up to 20°C (COR20; n = 6) or to 35°C (COR35; n = 6) by means 
of a programmable, external circulating cryo- thermostat. Overall perfu-
sion time was 90 minutes; the maximal temperature was reached within 
the first 60 minutes. Portal pressure was adjusted to 5 cm H2O, for tem-
peratures above 20°C, portal perfusion pressure was elevated to 8 cm 
H2O. Untreated livers that were only cold stored without end- ischemic 
rewarming served as controls (CS; n = 6).
2.2 | Isolated liver perfusion
Postpreservation recovery of all livers was evaluated after preser-
vation upon warm reperfusion in vitro in a recirculating system for 
120 minutes at 37°C. Prior to reperfusion, all livers were exposed to 
room temperature on a Petri dish for 20 minutes prior to reperfusion 
to simulate the ischemic period during surgical implantation in vivo. 
Oxygenated (95% O2 – 5% CO2; pO2 > 500 mm Hg) Williams E so-
lution (Sigma Aldrich, Germany), supplemented with 3 mg/100 mL 
of bovine serum albumin, was pumped through the portal vein at a 
constant flow of 3 mL/g min while the liver was placed floating in a 
bath of perfusion solution at 37°C. This setup has been previously 
validated and was shown to allow for adequate approximation of tis-
sue integrity and detection of structural changes in rat livers after hy-
pothermic preservation.14 Perfusate samples were taken after 15, 45, 
90, and 120 minutes of warm reperfusion.
2.3 | Detection of injury biomarkers
Enzyme activities of alanine aminotransferase (ALT) and aspartate 
aminotransferase (AST) in the perfusate were assessed in a routine 
fashion at the laboratory center of the University Hospital.
Perfusate pH, levels of glucose, and lactate were assessed using 
an acid base laboratory blood gas analyzer (ABL 800, Radiometer, 
Copenhagen, Denmark).
2.4 | Liver function
The common bile duct of the livers was cannulated with a 27- gauge 
polyethylene tubing. Bile was collected during the whole reperfusion 
period, and hepatic bile production was calculated as μL/g/h.
2.5 | Energetic status
Tissue specimens for assessment of high- energy phosphates were 
taken with precooled steel tongs, immersed in liquid nitrogen, and 
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stored	 at	 −80°C	 for	 later	 analysis.	Wet	weight	 of	 the	 frozen	 tissue	
samples was measured before they were lyophilized in a vacuum 
freezer	 (−60°C;	<0.025	mbar)	 for	at	 least	7	days	to	evaporate	tissue	
water. Freeze dried specimens were weighed again, and proteins were 
extracted with perchloric acid as described previously.15 Aliquots of 
the neutralized supernatant were used for determination of adeno-
sine triphosphate (ATP) by means of a commercial test kit (Abcam, 
Cambridge, UK) according to the manufacturer’s instructions. The re-
sults were corrected for the respective dry weight to wet weight ratio 
of the tissue samples and expressed as μmol/g dry weight.
2.6 | Histology
Liver tissue was collected at the conclusion of the experiments, cut into 
small blocks (3 mm thickness), and fixed by immersion in 4% buffered 
formalin. The blocks were embedded in paraffin, and 2- 4 mm tissue 
slides were prepared using a microtome (SM 2000R, Leica Instruments, 
Nußloch, Germany). Hematoxylin and eosin (H & E) staining was con-
ducted adherent to in- house standards and used to assess morphological 
integrity of the parenchyma. Sections were examined at 200- fold mag-
nification (Nikon Eclipse E800, Nikon, Tokyo, Japan) and the extent of 
necrotic injury was semiquantitatively graded in a 4- stage system ranging 
from 0 (no necrosis) to 3 (severe necrosis with disintegration of hepatic 
cords) as described elsewhere16 by two independent examiners.
2.7 | Statistics
All values are expressed as means ± SEM of n = 6 animals per group. 
Differences among the groups were tested by analysis of variances 
followed by the Student- Newman- Keuls test. Statistical significance 
was set at P less than .05.
3  | RESULTS
3.1 | Controlled oxygenated rewarming (COR)
Figure 1 shows the temperature kinetics during controlled rewarm-
ing up to 20°C or 35°C, respectively, as well as the corresponding 
flow volumes via the portal vein in the two groups. Venous ef-
fluent pO2 always stayed above 200 mm Hg, and perfusate con-
centrations of lactic acid remained below 1 mmol/L throughout 
the procedure in any group. Of note, perfusate concentrations of 
potassium remained stable during the first 60 minutes of perfu-
sion but then showed a slight declining tendency suggesting net 
absorption by hepatic metabolism. This pattern was similarly ob-
served in both groups but did not reach statistical significance. 
Perfusate pH during COR remained in the physiological range 
(7.35- 7.40) in both groups, and no additional equilibration was 
necessary.
Supplementary parameters related to liver integrity at the end of 
the rewarming machine perfusion are depicted in Table 1.
3.2 | Liver recovery upon reperfusion
Perfusate levels of hepatocellular enzymes, released upon reperfusion, 
were determined to characterize the effect of the different treatment 
arms on parenchymal liver damage (Figure 2). Notable concentrations 
of AST were found already early upon reperfusion of cold- stored liv-
ers and steadily increased thereafter. Controlled rewarming prior to 
reperfusion notably reduced the enzyme loss during the whole ob-
servation period. This reduction seemed to be more prominent after 
COR20 than after COR35, but no significant differences were dis-
closed between the two groups. Similar results were obtained with re-
gard to ALT, the leakage of which culminated to 338 ± 58, 123 ± 31*, 
and 185 ± 24* (CS vs COR20 vs COR35; *P	<	.05	vs	CS).	Resumption	
of metabolic activity of the livers is summarized in Table 1. Controlled 
rewarming up to either 20°C or 35°C significantly improved hepatic 
bile production upon reperfusion and also led to a better recovery 
of energetic status during reperfusion (cf. Table 2). While no differ-
ence could be substantiated between COR20 and COR35 for ener-
getic recovery, bile yield was somewhat lower after COR35 than after 
COR20.
Light microscopic evaluation of liver samples at the end of reper-
fusion was in line with the functional data. Severe alterations like ne-
crotic foci and hepatic chord disintegration were more abundant in the 
cold- stored livers than after controlled oxygenated rewarming leading 
F IGURE  1 Temperature kinetics, 
hepatic flow development, and perfusate 
potassium concentrations during controlled 
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to a significantly higher histological injury score in comparison with 
both of the treatment groups (cf. Figure 3).
3.3 | Correlation with functional recovery
Parameters obtained during COR were also scrutinized for their po-
tential to allow for prediction of hepatic recovery upon reperfusion. 
Inherent to the limitations of the in vitro model used, bile production 
upon reperfusion was chosen as the main indicator for functional 
liver recovery. During COR35, all of the livers already consistently 
exhibited a measurable bile production, which turned out to closely 
correlate with ulterior bile flow during reperfusion (cf. Figure 4). 
Bile production during COR20 was less consistent and in two cases 
not measurable, thus precluding this parameter to be used for pre-
diction of ulterior function. However, perfusate concentrations of 
potassium at the end of COR20 appeared to serve as a surrogate for 
functional measurements during COR, showing a correlation with 
ulterior bile production upon reperfusion of R2 = 0.87.
4  | DISCUSSION
The use of less than optimal organs in consequence to donor organ 
shortage provides new challenges in transplantation research with re-
spect to graft storage and reconditioning.17
During initial organ cold storage at 4°C, deprivation of oxygen9 as 
well as hypothermia itself,18 may adversely influence tissue state and 
trigger the induction of pro- inflammatory events and ulterior cell death.
Previous research indicated that main influence factors predicting 
the organ functionality and integrity after engraftment evolve upon 
reperfusion through reestablishment of the blood circulation.
The sudden temperature change from cold storage at 4°C to normo-
thermic conditions upon transplantation is suggested to negatively impact 
organ integrity and contribute to reperfusion- induced tissue injury.19
F IGURE  2 Hepatic release of aspartate aminotransferase (AST) 
upon reperfusion directly after cold storage (CS) and after interposed 






F IGURE  3 Liver tissue histology at the end of reperfusion after 
(A) cold storage (A, CS) or after controlled oxygenated rewarming up 




TABLE  1 Concentrations of lactate, liver enzyme activities (alanine 
aminotransferase—ALT and aspartate aminotransferase—AST) and 
differences of glucose concentration at 90 minutes minus 
concentration at 60 minutes20 in the perfusate upon controlled 
oxygenated rewarming up to 20°C (COR20) or 35°C (COR35)
COR20 COR35
Lactate (mmol/L) 0.5 ± 0.1 0.8 ± 0.1 ns
ALT (U/L) 7.7 ± 1.0 11.8 ± 1.6 ns
AST (U/L) 18.0 ± 3.6 33.0 ± 2.4 *
Delta Glucose (mg %) 8.7 ± 2.8 5.8 ± 1.1 ns
*P	<	.05.
ns: not significant—Student’s t- test.
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While machine perfusion with cold preservation solutions and 
controlled oxygenated rewarming up to mid- thermal temperatures has 
previously been described as a successful method to improve post- 
transplant outcome and to mitigate “rewarming injury” to the graft,11,20 
this is the first study to investigate controlled warming up from hypo-
thermia to normothermic temperature prior to warm reperfusion.
It was found that liver injury could be significantly reduced by the 
controlled rewarming technique, but in our model, the therapeutic ef-
fect could not be enhanced by extension of the rewarming process up 
to temperatures higher than 20°C.
However, Banan and coworkers, who only investigated abruptly 
started postpreservation perfusion with a sanguineous medium at 
20°C or 38°C, still found some protective effects in slowly increas-
ing temperature from 20°C to 38°C instead of immediate perfusion 
at 38°C.21
Notwithstanding that cell culture experiments from Rauen et al 
have demonstrated that the majority of cell damage, induced by rapid 
warming up of the medium are only observed upon transition from 
hypo- to midthermia (between 8 and 16°C), suggesting the “rewarm-
ing injury” to be operative predominantly at temperatures below 
 approximately 16°C.22
Therefore, it might be conjectured that controlling the tem-
perature rise up to 20°C might be a sufficient measure to mitigate 
rewarming injury in this context. Moreover, adequate restitution of 
cellular redox- homeostasis would not necessarily require normother-
mic temperatures.3,23
On the other hand, liver reconditioning at normothermia possibly 
might rely on the presence of oxygen carriers to solicit optimal results. 
At least for long- term liver perfusions, Alexander et al24 have sug-
gested oxygen carries to beneficially influence liver injury parameters 
in a rat liver model at fixed flow conditions. Likewise, Ferrigno et al25 
recently reported that hypoxic signaling (ie, upregulation of HIF- 1 
alpha) is triggered upon normothermic rat liver perfusion without oxy-
gen carriers at flow rates of 2.6 mL/g/min.
In our study, hepatic flow rates went somewhat higher and rose 
up to about 3 mL/g/min during normothermic perfusion and hepatic 
venous effluent partial pressures of oxygen never fell below 200 mm 
Hg during the controlled rewarming perfusion, which rather indicates 
adequate oxygen delivery to the tissue.
Notwithstanding, we cannot completely rule out the possibility that 
oxygen carriers might have improved the results in the COR35 group 
and this possibility should be kept in mind in further studies. However, 
detrimental effects of high oxygen delivery by artificial oxygen carriers 
have also been reported in postischemic cardiomyocytes.26
Another possible criticism of our COR35 protocol might be seen in 
the increased velocity of warming up in comparison with the COR20 
group. In preliminary experiments, we could not observe any im-
provements by extending the total period of controlled rewarming 
to 180 minutes instead of only 90 minutes, thus achieving a similar 
rate of tissue rewarming than in the COR20 group. In fact, the results 
turned out to be virtually identical to those after only 90 minutes of 
rewarming (eg, maximal release of AST: 432 ± 35 U/L; bile production 
upon reperfusion: 23.8 ± 5 μL/g/min). It was hence concluded that 
slowing down the time kinetic of warming up in the COR35 group is 
not of essence.
While not adding therapeutic benefits over the COR20 protocol, 
warming up to normothermia might foster evaluative purposes, as 
metabolic integrity would probably be best evaluated at circumstances 
of physiological homeostasis including temperature.
Moreover, the increased metabolism at higher temperatures should 
globally result in quantitative higher readouts for any parameter under 
investigation and thus possibly increase diagnostic discrimination.
In our experiments, increased metabolism and enhanced microcir-
culation at normothermic perfusion resulted in slightly, albeit mostly 
not significantly more elevated levels of lactate and transaminases in 
the perfusate. Likewise, hepatic net loss of glucose was reduced during 
machine perfusion at 35°C as compared to 20°C, putatively relating to 
incipient enhancement of glucose uptake by viable hepatocytes.
Bile production upon normothermic machine perfusion prior 
to transplantation has been proposed as easily and readily available 
predictive parameter,27 albeit without actual control by consecutive 
reperfusion experiments.
In our experiments, bile production was consistently observed 
during warming up to 35°C and did well correlate to ulterior liver 
function upon reperfusion. Further analysis of bile composition, as 
F IGURE  4 Correlation of bile 
production during controlled oxygenated 
rewarming up to 35°C (left) or 20°C 
(right) and subsequent bile flow upon 
postpreservation reperfusion
TABLE  2 Functional recovery and histological integrity of livers 
after cold storage (CS) or after interposed controlled oxygenated 
rewarming up to 20°C (COR20) or 35°C (COR35)
CS COR20 COR35
Bile (µL/g/h) 5.1 ± 1.9 37.4 ± 5.9* 22.1 ± 4.3*
ATP (µmol/g dw) 1.79 ± 0.07 2.56 ± 0.32* 2.44 ± 0.27*
Histoscore 2.8 ± 0.2 1.6 ± 0.1* 1.7 ± 0.1*
*P <	.05	vs	CS;	ANOVA	and	SNK-	test.
6 of 7  |     von HoRn et al.
previously proposed by the group of Porte,28 might have led to an even 
better quality of viability assessment. However, in our study on rat liv-
ers, we did not perform further analyses of the bile, due to the overall 
very limited quantities of bile produced during COR.
In agreement with the theoretical reduction in hepatic metab-
olism at lower temperatures, bile collection during COR20 was less 
consistent. Possibly, discriminative amounts of bile might be easier to 
obtain in a larger size model or in humans. However, surrogate read-
outs also easily available on site during machine perfusion and relating 
to structural liver injury were still useful to help viability assessment 
even at mid- thermic perfusion. Potassium, for instance, taken up by 
rewarmed hepatocytes upon energetic activation (eg, by Na+- K+- ATP- 
ase), results in lower K+ perfusate concentrations that are linked to 
resumption of liver metabolism and fairly well correlated with ulterior 
graft function upon reperfusion.
Due to the technical limitations, immanent to this small animal in 
vitro model, first conclusions have to be drawn carefully. However, 
controlled rewarming up to normothermia appears to be a feasible 
approach to gain functional data on graft viability prior to actual trans-
plantation. Notably, the higher metabolic rate at normothermia also 
increases the risk of adverse repercussions on graft integrity in case 
of inadequate perfusion conditions, either by model or by accident. 
Therefore, further studies are encouraged to validate and optimize 
technical details prior to final clinical recommendations.
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